Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Hepatitis A and B Vaccination Market Growth 2022-2028

  • LP 4973580
  • 111 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Hepatitis A and B Vaccination will have significant change from previous year. According to our (LP Information) latest study, the global Hepatitis A and B Vaccination market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hepatitis A and B Vaccination market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Hepatitis A and B Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis A and B Vaccination market, reaching US$ million by the year 2028. As for the Europe Hepatitis A and B Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Hepatitis A and B Vaccination players cover GSK, Merck, Sanofi, and Sinovac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A and B Vaccination market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Hepatitis A Vaccination

Hepatitis B Vaccination

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Government Institution

Private Sector

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCAMS

Convac

NCPC

Bio Kangtai

Dynavax

Hissen

LG Life Sciences

Serum Institute

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hepatitis A and B Vaccination Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hepatitis A and B Vaccination by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hepatitis A and B Vaccination by Country/Region, 2017, 2022 & 2028

2.2 Hepatitis A and B Vaccination Segment by Type

2.2.1 Hepatitis A Vaccination

2.2.2 Hepatitis B Vaccination

2.3 Hepatitis A and B Vaccination Sales by Type

2.3.1 Global Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

2.3.2 Global Hepatitis A and B Vaccination Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hepatitis A and B Vaccination Sale Price by Type (2017-2022)

2.4 Hepatitis A and B Vaccination Segment by Application

2.4.1 Government Institution

2.4.2 Private Sector

2.4.3 Other

2.5 Hepatitis A and B Vaccination Sales by Application

2.5.1 Global Hepatitis A and B Vaccination Sale Market Share by Application (2017-2022)

2.5.2 Global Hepatitis A and B Vaccination Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hepatitis A and B Vaccination Sale Price by Application (2017-2022)

3 Global Hepatitis A and B Vaccination by Company

3.1 Global Hepatitis A and B Vaccination Breakdown Data by Company

3.1.1 Global Hepatitis A and B Vaccination Annual Sales by Company (2020-2022)

3.1.2 Global Hepatitis A and B Vaccination Sales Market Share by Company (2020-2022)

3.2 Global Hepatitis A and B Vaccination Annual Revenue by Company (2020-2022)

3.2.1 Global Hepatitis A and B Vaccination Revenue by Company (2020-2022)

3.2.2 Global Hepatitis A and B Vaccination Revenue Market Share by Company (2020-2022)

3.3 Global Hepatitis A and B Vaccination Sale Price by Company

3.4 Key Manufacturers Hepatitis A and B Vaccination Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hepatitis A and B Vaccination Product Location Distribution

3.4.2 Players Hepatitis A and B Vaccination Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hepatitis A and B Vaccination by Geographic Region

4.1 World Historic Hepatitis A and B Vaccination Market Size by Geographic Region (2017-2022)

4.1.1 Global Hepatitis A and B Vaccination Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hepatitis A and B Vaccination Annual Revenue by Geographic Region

4.2 World Historic Hepatitis A and B Vaccination Market Size by Country/Region (2017-2022)

4.2.1 Global Hepatitis A and B Vaccination Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hepatitis A and B Vaccination Annual Revenue by Country/Region

4.3 Americas Hepatitis A and B Vaccination Sales Growth

4.4 APAC Hepatitis A and B Vaccination Sales Growth

4.5 Europe Hepatitis A and B Vaccination Sales Growth

4.6 Middle East & Africa Hepatitis A and B Vaccination Sales Growth

5 Americas

5.1 Americas Hepatitis A and B Vaccination Sales by Country

5.1.1 Americas Hepatitis A and B Vaccination Sales by Country (2017-2022)

5.1.2 Americas Hepatitis A and B Vaccination Revenue by Country (2017-2022)

5.2 Americas Hepatitis A and B Vaccination Sales by Type

5.3 Americas Hepatitis A and B Vaccination Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hepatitis A and B Vaccination Sales by Region

6.1.1 APAC Hepatitis A and B Vaccination Sales by Region (2017-2022)

6.1.2 APAC Hepatitis A and B Vaccination Revenue by Region (2017-2022)

6.2 APAC Hepatitis A and B Vaccination Sales by Type

6.3 APAC Hepatitis A and B Vaccination Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hepatitis A and B Vaccination by Country

7.1.1 Europe Hepatitis A and B Vaccination Sales by Country (2017-2022)

7.1.2 Europe Hepatitis A and B Vaccination Revenue by Country (2017-2022)

7.2 Europe Hepatitis A and B Vaccination Sales by Type

7.3 Europe Hepatitis A and B Vaccination Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hepatitis A and B Vaccination by Country

8.1.1 Middle East & Africa Hepatitis A and B Vaccination Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hepatitis A and B Vaccination Revenue by Country (2017-2022)

8.2 Middle East & Africa Hepatitis A and B Vaccination Sales by Type

8.3 Middle East & Africa Hepatitis A and B Vaccination Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hepatitis A and B Vaccination

10.3 Manufacturing Process Analysis of Hepatitis A and B Vaccination

10.4 Industry Chain Structure of Hepatitis A and B Vaccination

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hepatitis A and B Vaccination Distributors

11.3 Hepatitis A and B Vaccination Customer

12 World Forecast Review for Hepatitis A and B Vaccination by Geographic Region

12.1 Global Hepatitis A and B Vaccination Market Size Forecast by Region

12.1.1 Global Hepatitis A and B Vaccination Forecast by Region (2023-2028)

12.1.2 Global Hepatitis A and B Vaccination Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hepatitis A and B Vaccination Forecast by Type

12.7 Global Hepatitis A and B Vaccination Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Hepatitis A and B Vaccination Product Offered

13.1.3 GSK Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Hepatitis A and B Vaccination Product Offered

13.2.3 Merck Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Hepatitis A and B Vaccination Product Offered

13.3.3 Sanofi Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Sinovac

13.4.1 Sinovac Company Information

13.4.2 Sinovac Hepatitis A and B Vaccination Product Offered

13.4.3 Sinovac Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sinovac Main Business Overview

13.4.5 Sinovac Latest Developments

13.5 Zhejiang Pukang

13.5.1 Zhejiang Pukang Company Information

13.5.2 Zhejiang Pukang Hepatitis A and B Vaccination Product Offered

13.5.3 Zhejiang Pukang Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Zhejiang Pukang Main Business Overview

13.5.5 Zhejiang Pukang Latest Developments

13.6 Changchun Institute of Biological

13.6.1 Changchun Institute of Biological Company Information

13.6.2 Changchun Institute of Biological Hepatitis A and B Vaccination Product Offered

13.6.3 Changchun Institute of Biological Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Changchun Institute of Biological Main Business Overview

13.6.5 Changchun Institute of Biological Latest Developments

13.7 KM Biologics

13.7.1 KM Biologics Company Information

13.7.2 KM Biologics Hepatitis A and B Vaccination Product Offered

13.7.3 KM Biologics Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 KM Biologics Main Business Overview

13.7.5 KM Biologics Latest Developments

13.8 IMBCAMS

13.8.1 IMBCAMS Company Information

13.8.2 IMBCAMS Hepatitis A and B Vaccination Product Offered

13.8.3 IMBCAMS Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 IMBCAMS Main Business Overview

13.8.5 IMBCAMS Latest Developments

13.9 Convac

13.9.1 Convac Company Information

13.9.2 Convac Hepatitis A and B Vaccination Product Offered

13.9.3 Convac Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Convac Main Business Overview

13.9.5 Convac Latest Developments

13.10 NCPC

13.10.1 NCPC Company Information

13.10.2 NCPC Hepatitis A and B Vaccination Product Offered

13.10.3 NCPC Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 NCPC Main Business Overview

13.10.5 NCPC Latest Developments

13.11 Bio Kangtai

13.11.1 Bio Kangtai Company Information

13.11.2 Bio Kangtai Hepatitis A and B Vaccination Product Offered

13.11.3 Bio Kangtai Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bio Kangtai Main Business Overview

13.11.5 Bio Kangtai Latest Developments

13.12 Dynavax

13.12.1 Dynavax Company Information

13.12.2 Dynavax Hepatitis A and B Vaccination Product Offered

13.12.3 Dynavax Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Dynavax Main Business Overview

13.12.5 Dynavax Latest Developments

13.13 Hissen

13.13.1 Hissen Company Information

13.13.2 Hissen Hepatitis A and B Vaccination Product Offered

13.13.3 Hissen Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hissen Main Business Overview

13.13.5 Hissen Latest Developments

13.14 LG Life Sciences

13.14.1 LG Life Sciences Company Information

13.14.2 LG Life Sciences Hepatitis A and B Vaccination Product Offered

13.14.3 LG Life Sciences Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 LG Life Sciences Main Business Overview

13.14.5 LG Life Sciences Latest Developments

13.15 Serum Institute

13.15.1 Serum Institute Company Information

13.15.2 Serum Institute Hepatitis A and B Vaccination Product Offered

13.15.3 Serum Institute Hepatitis A and B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Serum Institute Main Business Overview

13.15.5 Serum Institute Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Hepatitis A and B Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hepatitis A and B Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hepatitis A Vaccination

Table 4. Major Players of Hepatitis B Vaccination

Table 5. Global Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)

Table 6. Global Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

Table 7. Global Hepatitis A and B Vaccination Revenue by Type (2017-2022) & ($ million)

Table 8. Global Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2022)

Table 9. Global Hepatitis A and B Vaccination Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)

Table 11. Global Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Table 12. Global Hepatitis A and B Vaccination Revenue by Application (2017-2022)

Table 13. Global Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2022)

Table 14. Global Hepatitis A and B Vaccination Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Hepatitis A and B Vaccination Sales by Company (2020-2022) & (Units)

Table 16. Global Hepatitis A and B Vaccination Sales Market Share by Company (2020-2022)

Table 17. Global Hepatitis A and B Vaccination Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Hepatitis A and B Vaccination Revenue Market Share by Company (2020-2022)

Table 19. Global Hepatitis A and B Vaccination Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Hepatitis A and B Vaccination Producing Area Distribution and Sales Area

Table 21. Players Hepatitis A and B Vaccination Products Offered

Table 22. Hepatitis A and B Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Hepatitis A and B Vaccination Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Hepatitis A and B Vaccination Sales Market Share Geographic Region (2017-2022)

Table 27. Global Hepatitis A and B Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Hepatitis A and B Vaccination Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Hepatitis A and B Vaccination Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Hepatitis A and B Vaccination Sales Market Share by Country/Region (2017-2022)

Table 31. Global Hepatitis A and B Vaccination Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Hepatitis A and B Vaccination Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)

Table 34. Americas Hepatitis A and B Vaccination Sales Market Share by Country (2017-2022)

Table 35. Americas Hepatitis A and B Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Hepatitis A and B Vaccination Revenue Market Share by Country (2017-2022)

Table 37. Americas Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)

Table 38. Americas Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

Table 39. Americas Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)

Table 40. Americas Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Table 41. APAC Hepatitis A and B Vaccination Sales by Region (2017-2022) & (Units)

Table 42. APAC Hepatitis A and B Vaccination Sales Market Share by Region (2017-2022)

Table 43. APAC Hepatitis A and B Vaccination Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Hepatitis A and B Vaccination Revenue Market Share by Region (2017-2022)

Table 45. APAC Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)

Table 46. APAC Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

Table 47. APAC Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)

Table 48. APAC Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Table 49. Europe Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)

Table 50. Europe Hepatitis A and B Vaccination Sales Market Share by Country (2017-2022)

Table 51. Europe Hepatitis A and B Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Hepatitis A and B Vaccination Revenue Market Share by Country (2017-2022)

Table 53. Europe Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)

Table 54. Europe Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

Table 55. Europe Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)

Table 56. Europe Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Hepatitis A and B Vaccination Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Hepatitis A and B Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Hepatitis A and B Vaccination Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Hepatitis A and B Vaccination Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Hepatitis A and B Vaccination

Table 66. Key Market Challenges & Risks of Hepatitis A and B Vaccination

Table 67. Key Industry Trends of Hepatitis A and B Vaccination

Table 68. Hepatitis A and B Vaccination Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Hepatitis A and B Vaccination Distributors List

Table 71. Hepatitis A and B Vaccination Customer List

Table 72. Global Hepatitis A and B Vaccination Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Hepatitis A and B Vaccination Sales Market Forecast by Region

Table 74. Global Hepatitis A and B Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Hepatitis A and B Vaccination Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Hepatitis A and B Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Hepatitis A and B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Hepatitis A and B Vaccination Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Hepatitis A and B Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Hepatitis A and B Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Hepatitis A and B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Hepatitis A and B Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Hepatitis A and B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Hepatitis A and B Vaccination Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Hepatitis A and B Vaccination Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Hepatitis A and B Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Hepatitis A and B Vaccination Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Hepatitis A and B Vaccination Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Hepatitis A and B Vaccination Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Hepatitis A and B Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Hepatitis A and B Vaccination Revenue Market Share Forecast by Application (2023-2028)

Table 92. GSK Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Hepatitis A and B Vaccination Product Offered

Table 94. GSK Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Merck Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Hepatitis A and B Vaccination Product Offered

Table 99. Merck Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Sanofi Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Hepatitis A and B Vaccination Product Offered

Table 104. Sanofi Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Sinovac Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 108. Sinovac Hepatitis A and B Vaccination Product Offered

Table 109. Sinovac Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Sinovac Main Business

Table 111. Sinovac Latest Developments

Table 112. Zhejiang Pukang Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 113. Zhejiang Pukang Hepatitis A and B Vaccination Product Offered

Table 114. Zhejiang Pukang Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Zhejiang Pukang Main Business

Table 116. Zhejiang Pukang Latest Developments

Table 117. Changchun Institute of Biological Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 118. Changchun Institute of Biological Hepatitis A and B Vaccination Product Offered

Table 119. Changchun Institute of Biological Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Changchun Institute of Biological Main Business

Table 121. Changchun Institute of Biological Latest Developments

Table 122. KM Biologics Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 123. KM Biologics Hepatitis A and B Vaccination Product Offered

Table 124. KM Biologics Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. KM Biologics Main Business

Table 126. KM Biologics Latest Developments

Table 127. IMBCAMS Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 128. IMBCAMS Hepatitis A and B Vaccination Product Offered

Table 129. IMBCAMS Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. IMBCAMS Main Business

Table 131. IMBCAMS Latest Developments

Table 132. Convac Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 133. Convac Hepatitis A and B Vaccination Product Offered

Table 134. Convac Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Convac Main Business

Table 136. Convac Latest Developments

Table 137. NCPC Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 138. NCPC Hepatitis A and B Vaccination Product Offered

Table 139. NCPC Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. NCPC Main Business

Table 141. NCPC Latest Developments

Table 142. Bio Kangtai Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 143. Bio Kangtai Hepatitis A and B Vaccination Product Offered

Table 144. Bio Kangtai Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Bio Kangtai Main Business

Table 146. Bio Kangtai Latest Developments

Table 147. Dynavax Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 148. Dynavax Hepatitis A and B Vaccination Product Offered

Table 149. Dynavax Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Dynavax Main Business

Table 151. Dynavax Latest Developments

Table 152. Hissen Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 153. Hissen Hepatitis A and B Vaccination Product Offered

Table 154. Hissen Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Hissen Main Business

Table 156. Hissen Latest Developments

Table 157. LG Life Sciences Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 158. LG Life Sciences Hepatitis A and B Vaccination Product Offered

Table 159. LG Life Sciences Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. LG Life Sciences Main Business

Table 161. LG Life Sciences Latest Developments

Table 162. Serum Institute Basic Information, Hepatitis A and B Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 163. Serum Institute Hepatitis A and B Vaccination Product Offered

Table 164. Serum Institute Hepatitis A and B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Serum Institute Main Business

Table 166. Serum Institute Latest Developments

List of Figures

Figure 1. Picture of Hepatitis A and B Vaccination

Figure 2. Hepatitis A and B Vaccination Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hepatitis A and B Vaccination Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Hepatitis A and B Vaccination Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hepatitis A and B Vaccination Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hepatitis A Vaccination

Figure 10. Product Picture of Hepatitis B Vaccination

Figure 11. Global Hepatitis A and B Vaccination Sales Market Share by Type in 2021

Figure 12. Global Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2022)

Figure 13. Hepatitis A and B Vaccination Consumed in Government Institution

Figure 14. Global Hepatitis A and B Vaccination Market: Government Institution (2017-2022) & (Units)

Figure 15. Hepatitis A and B Vaccination Consumed in Private Sector

Figure 16. Global Hepatitis A and B Vaccination Market: Private Sector (2017-2022) & (Units)

Figure 17. Hepatitis A and B Vaccination Consumed in Other

Figure 18. Global Hepatitis A and B Vaccination Market: Other (2017-2022) & (Units)

Figure 19. Global Hepatitis A and B Vaccination Sales Market Share by Application (2017-2022)

Figure 20. Global Hepatitis A and B Vaccination Revenue Market Share by Application in 2021

Figure 21. Hepatitis A and B Vaccination Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Hepatitis A and B Vaccination Revenue Market Share by Company in 2021

Figure 23. Global Hepatitis A and B Vaccination Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Hepatitis A and B Vaccination Revenue Market Share by Geographic Region in 2021

Figure 25. Global Hepatitis A and B Vaccination Sales Market Share by Region (2017-2022)

Figure 26. Global Hepatitis A and B Vaccination Revenue Market Share by Country/Region in 2021

Figure 27. Americas Hepatitis A and B Vaccination Sales 2017-2022 (Units)

Figure 28. Americas Hepatitis A and B Vaccination Revenue 2017-2022 ($ Millions)

Figure 29. APAC Hepatitis A and B Vaccination Sales 2017-2022 (Units)

Figure 30. APAC Hepatitis A and B Vaccination Revenue 2017-2022 ($ Millions)

Figure 31. Europe Hepatitis A and B Vaccination Sales 2017-2022 (Units)

Figure 32. Europe Hepatitis A and B Vaccination Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Hepatitis A and B Vaccination Sales 2017-2022 (Units)

Figure 34. Middle East & Africa Hepatitis A and B Vaccination Revenue 2017-2022 ($ Millions)

Figure 35. Americas Hepatitis A and B Vaccination Sales Market Share by Country in 2021

Figure 36. Americas Hepatitis A and B Vaccination Revenue Market Share by Country in 2021

Figure 37. United States Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Hepatitis A and B Vaccination Sales Market Share by Region in 2021

Figure 42. APAC Hepatitis A and B Vaccination Revenue Market Share by Regions in 2021

Figure 43. China Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Hepatitis A and B Vaccination Sales Market Share by Country in 2021

Figure 50. Europe Hepatitis A and B Vaccination Revenue Market Share by Country in 2021

Figure 51. Germany Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Hepatitis A and B Vaccination Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Hepatitis A and B Vaccination Revenue Market Share by Country in 2021

Figure 58. Egypt Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Hepatitis A and B Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Hepatitis A and B Vaccination in 2021

Figure 64. Manufacturing Process Analysis of Hepatitis A and B Vaccination

Figure 65. Industry Chain Structure of Hepatitis A and B Vaccination

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370